FINWIRES · TerminalLIVE
FINWIRES

Top Midday Decliners

By

Coastal Financial (CCB) swung to a Q2 loss while revenue increased from a year ago, it said Thursday.

Shares of the financial services firm slumped 42% as intraday trading volume jumped to over 1.08 million from a daily average of about 129,000.

Alnylam Pharmaceuticals (ALNY) lowered its full-year 2026 net product revenue guidance, taking the shine off higher Q2 non-GAAP earnings and revenue reported Thursday.

Shares of the pharma company sank nearly 29%, with intraday trading volume rising to over 6.1 million from a daily average of roughly 1.28 million.

Meta Platforms (META) set out a soft Q3 revenue outlook following an unexpected year-over-year decline in quarterly earnings released overnight.

Meta also raised the lower end of its capital expenditure guidance.

Shares of the Facebook owner dropped 9% as intraday trading volume climbed to over 29.3 million from the stock's daily average of about 17.7 million.

Price: $532.29, Change: $-53.33, Percent Change: -9.11%

Related Articles

Wire

Houlihan Lokey Fiscal Q1 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Houlihan Lokey (HLI) reported fiscal Q1 adjusted earnings late Wednesday of $1.35 per diluted share, down from $2.14 a year earlier.Analysts polled by FactSet expected $1.64.Revenue in the three months ended June 30 fell to $511 million from $605 million a year earlier.Analysts expected $602.4 million.Houlihan Lokey shares fell 6.6% in after-hours trading.

$HLI
Wire

Four Corners Property Trust Q2 AFFO, Revenue Rise

Four Corners Property Trust (FCPT) reported Q2 adjusted funds from operations late Wednesday of $0.45 per diluted share, up from $0.44 a year earlier.Analysts polled by FactSet expected $0.45.Revenue in the quarter ended June 30 rose to $78.4 million from $72.8 million a year earlier.Four analysts expected $79 million.The company's shares rose 2% in after-hours trading.

$FCPT
Wire

Corcept Therapeutics Q2 Earnings, Revenue Rise; Shares Jump After Hours

Corcept Therapeutics (CORT) reported Q2 earnings late Wednesday of $0.36 per diluted share, up from $0.29 a year earlier.Analysts polled by FactSet expected $0.02.Revenue for the three months ended June 30 rose to $256.1 million from $194.4 million a year earlier.Analysts expected $221.1 million.The company boosted full-year revenue guidance to $1.1 billion to $1.2 billion from the prior forecast of $950 million to $1.05 billion.Analysts project $999.5 million.Corcept shares jumped 18% in after-hours trading.

$CORT